Steelman LS - Search Results

1

PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches.

Ligresti G, Militello L, Steelman LS, Cavallaro A, Basile F, Nicoletti F, Stivala F, McCubrey JA, Libra M. Ligresti G, et al. Among authors: steelman ls. Cell Cycle. 2009 May 1;8(9):1352-8. doi: 10.4161/cc.8.9.8255. Epub 2009 May 23. Cell Cycle. 2009. PMID: 19305151 Free PMC article. Review.

2

Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells.

Fitzgerald TL, Lertpiriyapong K, Cocco L, Martelli AM, Libra M, Candido S, Montalto G, Cervello M, Steelman L, Abrams SL, McCubrey JA. Fitzgerald TL, et al. Adv Biol Regul. 2015 Sep;59:65-81. doi: 10.1016/j.jbior.2015.06.003. Epub 2015 Jul 17. Adv Biol Regul. 2015. PMID: 26257206 Review.

3

Metformin influences drug sensitivity in pancreatic cancer cells.

Candido S, Abrams SL, Steelman L, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Lombardi P, Montalto G, Cervello M, Gizak A, Rakus D, Suh PG, Libra M, McCubrey JA. Candido S, et al. Adv Biol Regul. 2018 May;68:13-30. doi: 10.1016/j.jbior.2018.02.002. Epub 2018 Feb 12. Adv Biol Regul. 2018. PMID: 29482945

4

Raf-induced cell cycle progression in human TF-1 hematopoietic cells.

Chang F, Steelman LS, McCubrey JA. Chang F, et al. Among authors: steelman ls. Cell Cycle. 2002 May-Jun;1(3):220-6. Cell Cycle. 2002. PMID: 12429936

5

Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.

Shelton JG, Steelman LS, White ER, McCubrey JA. Shelton JG, et al. Among authors: steelman ls. Cell Cycle. 2004 Mar;3(3):372-9. Epub 2004 Mar 1. Cell Cycle. 2004. PMID: 14726697

6

Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.

Shelton JG, Blalock WL, White ER, Steelman LS, McCubrey JA. Shelton JG, et al. Among authors: steelman ls. Cell Cycle. 2004 Apr;3(4):503-12. Epub 2004 Apr 1. Cell Cycle. 2004. PMID: 15004527

7

Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells.

Lee JT, Steelman LS, Chappell WH, McCubrey JA. Lee JT, et al. Among authors: steelman ls. Cell Cycle. 2008 Mar 1;7(5):631-6. doi: 10.4161/cc.7.5.5416. Epub 2007 Dec 6. Cell Cycle. 2008. PMID: 18256541

8

Targeting prostate cancer based on signal transduction and cell cycle pathways.

Lee JT, Lehmann BD, Terrian DM, Chappell WH, Stivala F, Libra M, Martelli AM, Steelman LS, McCubrey JA. Lee JT, et al. Among authors: steelman ls. Cell Cycle. 2008 Jun 15;7(12):1745-62. doi: 10.4161/cc.7.12.6166. Epub 2008 Jun 16. Cell Cycle. 2008. PMID: 18594202 Free PMC article. Review.

9

Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs.

Steelman LS, Abrams SL, Shelton JG, Chappell WH, Bäsecke J, Stivala F, Donia M, Nicoletti F, Libra M, Martelli AM, McCubrey JA. Steelman LS, et al. Cell Cycle. 2010 Apr 15;9(8):1629-38. doi: 10.4161/cc.9.8.11487. Epub 2010 Apr 15. Cell Cycle. 2010. PMID: 20372086 Free PMC article.

10

Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Abrams SL, Steelman LS, Shelton JG, Chappell W, Bäsecke J, Stivala F, Donia M, Nicoletti F, Libra M, Martelli AM, McCubrey JA. Abrams SL, et al. Among authors: steelman ls. Cell Cycle. 2010 May;9(9):1839-46. doi: 10.4161/cc.9.9.11544. Epub 2010 May 15. Cell Cycle. 2010. PMID: 20436269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters